Status:

COMPLETED

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis

Lead Sponsor:

PETHEMA Foundation

Conditions:

Acute Myeloid Leukemia

Allogeneic Haematopoietic Progenitor Cell Transplant

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The trial is planned as a multicentric, national, phase II, open-label trial to evaluate safety and tolerance of nebulized Liposomal Amphotericin B (Ambisome) for LMA patients during the induction the...

Detailed Description

The invasive fungal infection (IFI) is the most common cause of mortality related to autologous stem cell transplant. Taking into account that Saprophytic Aspergillus is usually acquired by inhalation...

Eligibility Criteria

Inclusion

  • Patient has decided voluntary to consent his or her participation signing the consent form before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to their future medical care.
  • Patients with Acute myeloid Leukemia (AML), that will start induction chemotherapy or those patients submitted to an Allogeneic haematopoietic progenitor cell transplant.
  • The patient is \>18 years old.

Exclusion

  • Patient with prior Invasive Pulmonary Aspergillosis (IPA) history.
  • History of allergy or hypersensitivity to Amphotericin B.
  • Patient with intellectual deficit or patients with psychological alterations that make impossible the trial understanding.
  • Pregnancy or breastfeeding.
  • Patient has received other investigational drug or non traded product within 30 days before trial beginning.
  • Patient is enrolled in another clinical research study or/and is receiving an investigational agent for any reason.
  • Patient had major surgery within 4 weeks before enrollment.

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2009

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00391014

Start Date

January 1 2006

End Date

April 1 2009

Last Update

May 12 2009

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hospital de la Santa Creu i Sant Pau

Barcelona, Barcelona, Spain

2

Hospital Universitario de la Princesa

Madrid, Madrid, Spain

3

Hospital Universitario la Fe

Valencia, Valencia, Spain

4

Hospital Universitario de Salamanca

Salamanca, Spain